Wound management is highly fragmented and competitive

The wound care industry is highly fragmented, with around eight large companies leading the pack, but with hundreds—some say thousands—of small cap companies also manufacturing and marketing wound care products. The space is attractive, because even small companies can experience a sudden rise in market share and profits if they are able to develop a medical manufacturing breakthrough.


Source: Report #S251.

This market has a low level of concentration, meaning that no single global company, a list that includes Johnson & Johnson, Acelity LP, Inc., 3M Health Care and Smith & Nephew, dominates the market. Another half-dozen manufacturers have less than 10% market share, while ‘Others,’ which represents the hundreds of additional companies active in this space, accounts for the largest share of the wound care market. The field is crowded and highly fragmented. Barriers to entry vary by product, with the traditional segments having relatively low barriers to entry, while Growth Factors, for example, requires the potential manufacturer to possess specific, highly-technical information and physical equipment in order to enter the field.

To take a couple of examples of the high density of manufacturers in these product segments, the Foam Dressings segment includes 3M, B. Braun, BSN Medical, Coloplast, ConvaTec, Covalon Technologies, Medtronic, Derma Sciences, Hartmann Group, Hollister and many more. In the multimillion dollar NPWT industry, key players include Smith & Nephew, wound care specialists Kinetic Concepts (KCI, now owned by Acelity LP, Inc.), Prospera, Talley Group Ltd, Convatec, Mölnlycke Health Care AB, ArjoHuntleigh Healthcare Ltd, Medela, Inc., and Genadyne.

From, “Wound Management, Forecast to 2024: Established and Emerging Products, Technologies, and Market in the Americas, Europe, Asia/Pacific, and Rest of World.” Report #S251.